ABSTRACT Transient receptor potential vanilloid 1 (TRPV1) is a nonselective ligand-gated cation channel responding to noxious heat, protons, and chemicals such as capsaicin. TRPV1 is expressed in sensory neurons and plays a critical role in pain associated with tissue injury, inflammation, and nerve lesions. Transient receptor potential ankyrin 1 (TRPA1) is coexpressed with TRPV1. It is activated by compounds that cause a burning sensation (e.g., mustard oil) and, indirectly, by components of the inflammatory milieu eliciting nociceptor excitation and pain hypersensitivity. Previous studies indicate an interaction of TRPV1 and TRPA1 signaling pathways. Here we sought to examine the molecular mechanisms underlying such interactions in nociceptive neurons. We first excluded physical interactions of both channels using radioligand binding studies. By microfluorimetry, electrophysiological experiments, cAMP measurements, and site-directed mutagenesis we found a sensitization of TRPV1 after TRPA1 stimulation with mustard oil in a calcium and cAMP/protein kinase A (PKA)-dependent manner. TRPA1 stimulation enhanced TRPV1 phosphorylation via the putative PKA phosphorylation site serine 116. We also detected calcium-sensitive increased TRPV1 activity after TRPA1 activation in dorsal root ganglion neurons. The inhibition of TRPA1 by HC-030031 (1,2,3,6-tetrahydro-1,3-dimethyl-N-[4-(1-methylethyl)phenyl]-2,6-dioxo-7H-purine-7-acetamide, 2-(1,3-dimethyl-2,6-dioxo-1,2,3,6-tetrahydro-7H-purin-7-yl)-N-(4-isopropylphenyl)acetamide) after its initial stimulation (and the calcium-insensitive TRPA1 mutant D477A) still showed increased capsaicin-induced TRPV1 activity. This excludes a calcium-induced additive TRPA1 current after TRPV1 stimulation. Our study shows sensitization of TRPV1 via activation of TRPA1, which involves adenylyl cyclase, increased cAMP, subsequent translocation and activation of PKA, and phosphorylation of TRPV1 at PKA phosphorylation residues. This suggests that cross-sensitization of TRP channels contributes to enhanced pain sensitivity in inflamed tissues.
Introduction
The transduction and transmission of painful stimuli are initiated by activation of nociceptive dorsal root ganglion (DRG) neurons, which convey information to the central nervous system, resulting in the sensation of pain (Tominaga, 2007) . The transient receptor potential (TRP) ion channel family plays essential roles in such responses (Venkatachalam and Montell, 2007) . Important and extensively investigated are TRP vanilloid 1 (TRPV1) and TRP ankyrin 1 (TRPA1). Both are nonselective cation channels sharing the common feature of six transmembrane domains and intracellular N and C termini. One functional channel is formed by four monomers (Venkatachalam and Montell, 2007) . Both channels play crucial roles in neurogenic inflammation (reviewed in Geppetti et al., 2008) and in the development of hyperalgesia (Tominaga et al., 1998; Davis et al., 2000; Obata et al., 2005; Bautista et al., 2006; Petrus et al., 2007; Spahn et al., 2013) . Additionally, it was shown that 97% of TRPA1-positive sensory neurons also express TRPV1, and that 30% of TRPV1-positive neurons coexpress TRPA1 (Story et al., 2003) . Since previous studies indicated modulating effects of TRPA1 stimulation on TRPV1 activity (Jeske et al., 2006; Akopian et al., 2008; Anand et al., 2008) , we sought to investigate the underlying mechanisms at the molecular level.
TRPV1-expressing DRG neurons respond to temperatures above 43°C, protons, and chemical stimuli such as capsaicin (Caterina et al., 1997 (Caterina et al., , 2000 . This channel features several putative phosphorylation sites that can be modulated by the cAMP/protein kinase A (PKA) pathway (reviewed in Tominaga and Tominaga, 2005) . Important sites are serine 6, serine 116, threonine 144, threonine 370, serine 502, serine 774, and serine 820 (Bhave et al., 2002; .
TRPA1 is the sole vertebrate member of the TRPA family (Venkatachalam and Montell, 2007; Tai et al., 2008) . Initially TRPA1 was proposed to be the sensor of noxious cold, albeit TRPA1 knockout mice yielded controversial results (Story et al., 2003; Bandell et al., 2004; Bautista et al., 2006; Kwan et al., 2006) . This channel is also activated by the chemicals allyl isothiocyanate (an ingredient of mustard, horseradish, and wasabi), allicin, diallyl disulfide (in garlic), cinnamaldehyde (in cinnamon), and acrolein (in tear gas) through covalent modifications of cysteine residues. In vivo, the topical application of mustard oil (MO) to the skin produces pain, inflammation, and hypersensitivity to thermal and mechanical stimulation (Jordt et al., 2004) . Additionally, TRPA1 can be activated by cannabinoids and intracellular calcium, which modulates the channel via a partial EF-hand domain at the N terminus (Jordt et al., 2004; Doerner et al., 2007; Zurborg et al., 2007) .
Similar to the TRPV subfamily, TRPA1 features a tetrameric arrangement with a dense transmembrane region and a basketlike cytoplasmic domain structure. However, the intracellular termini differ from other TRP channels in that the N terminus consists of numerous ankyrin repeats (Bessac and Jordt, 2008; Cvetkov et al., 2011; Premkumar and Abooj, 2013. In the current study we sought to investigate the molecular mechanisms underlying the effects of TRPA1 activation on TRPV1, since this interaction is of great interest for the development of novel pain therapies in the context of inflammation. To this end, we used microfluorimetry, electrophysiology, radioligand binding studies, and site-directed mutagenesis. We hypothesized that MO-induced calcium influx through TRPA1 results in the activation of calcium-sensitive adenylyl cyclases (ACs), which produce intracellular cAMP. The latter might stimulate PKA to phosphorylate and sensitize TRPV1.
Materials and Methods
Cell Culture. Experiments were performed in human embryonic kidney (HEK) 293 Tet-On cells because they do not constitutively express TRPV1 or TRPA1. The HEK 293 Tet-On cell line (kindly provided by P. Heppenstall and S. Zurborg) stably expresses a reverse tetracycline-controlled transactivator protein, providing the ability of high expression levels after addition of doxycycline to the culture medium. This way, the known cell toxicity due to constitutive expression of TRPA1 is prevented (Story et al., 2003) .
HEK 293 Tet-On cells were maintained in minimum essential media (MEM) a medium supplemented with 10% Tet system-approved fetal bovine serum, 1% penicillin/streptomycin, 4 mM L-glutamine, and 200 mg/ml geneticin (G418) at 37°C and 5% CO 2 in a cell incubator. They were passaged 1:3-1:10 every second to third day depending on the confluence. DRG were prepared as described previously (Bolyard et al., 2000) . Briefly, thoracic and lumbar DRG of male Wistar rats were removed and placed in sterile MEM at 4°C. DRG were digested with collagenase type 2 in MEM at 37°C for 50 minutes, and with 0.025% trypsin for 10 minutes at 37°C. After digestion, DRG were carefully dissociated by mechanical agitation, centrifuged at 500g for 5 minutes, and then at 300g for 5 minutes. The cells were maintained in MEM (Biochrom AG, Berlin, Germany) growth media supplemented with 10% horse serum, 50 mg/ml penicillin and streptomycin, and plated in 35-mm poly(lysine)-coated culture dishes at 37°C in an atmosphere of 5% CO 2 (Spahn et al., 2013) .
Site-Directed Mutagenesis and Heterologous Expression. Mutagenesis of several PKA phosphorylation sites of TRPV1 cDNA was realized with TRPV1-pcDNA3.1, using a site-directed mutagenesis kit (Stratagene, La Jolla, CA) as described previously . All constructs were confirmed by DNA sequencing by a commercial provider (LCG Genomics, Berlin, Germany) (Spahn et al., 2013) . The TRPA1 mutant D477A was kindly provided by S. Zurborg and P. Heppenstall.
Heterologous expression of wild-type (wt) or mutant plasmids of TRPV1 (Rattus norvegicus) (0.5 mg) and wild-type or mutant TRPA1 (Homo sapiens) (0.5 mg) was achieved using Fugene 6 or XtremeGENE DNA transfection reagent (Roche Diagnostics, Indianapolis, IN). Gene expression was induced after addition of 1 mg/ml doxycycline, and experiments were performed 24 hours after transfection. Transfection-positive cells were identified by yellow fluorescent protein-tagged TRPV1 receptors. All cells responding to MO also responded to capsaicin, indicating coexpression of TRPA1 and TRPV1.
Treatments. TRPV1 and TRPA1 coexpressing HEK 293 Tet-On cells or DRG neurons were preincubated with MO (20 mM) or cinnamaldehyde (CA) (100 mM) for 2 minutes, followed by a 1-minute washout with buffer (shown for MO and CA preincubation in Fig. 1 ) unless otherwise noted. Thereafter, cells were stimulated with capsaicin. Control cells were treated with the corresponding buffer for 3 minutes, followed by capsaicin. To examine whether the capsaicin-induced current is a result of an additive TRPA1 current, cells were perfused with the TRPA1 inhibitor HC-030031 (1,2,3,6-tetrahydro-1,3-dimethyl-N-[4-(1-methylethyl)phenyl]-2,6-dioxo-7H-purine-7-acetamide, 2-(1,3-dimethyl-2,6-dioxo-1,2,3,6-tetrahydro-7H-purin-7-yl)-N-(4-isopropylphenyl)acetamide) (25 mM) (Sigma-Aldrich, Steinheim, Germany) for 1 minute immediately after the MO-induced TRPA1 current. Thereafter, they were stimulated with capsaicin in the presence of HC-030031. In these experiments control cells were pretreated with buffer for 2 minutes, and afterward with buffer containing HC-030031 (25 mM) for 1 minute.
To completely block TRPA1 activity a priori, HC-030031 was applied simultaneously with MO for 2 minutes, followed by a 1-minute washout and capsaicin stimulation. Control cells were treated with buffer for 3 minutes followed by capsaicin application.
To simulate calcium-free conditions in patch-clamp experiments, cells were washed and incubated with Ca 21 -free extracellular solution (ECS) complemented with EGTA (100 mM) (ECS Ca 21 -free) before the recording of currents. To inhibit PKA, cells were incubated with H89 (N-[2-(p-bromocinnamylamino)ethyl]-5-isoquinolinesulfonamide·2HCl) (Sigma-Aldrich) (10 mM) for at least 6 hours prior to the experiment. The activity of AC was inhibited by the addition of 100 mM 9-(tetrahydro-2-furanyl)-9H-purin-6-amine (SQ 22.536) (Sigma-Aldrich) for 10 minutes.
Patch-Clamp Recordings. Whole-cell voltage-clamp recordings were performed in HEK 293 Tet-On cells and dissociated small-sized DRG neurons at 260 mV holding potential with an EPC-10 patchclamp amplifier and PULSE software (HEKA Elektronik, Lambrecht, Germany). Borosilicate glass electrodes (Hilgenberg, Malsfeld, Germany), pulled on a horizontal puller (Sutter Instrument Company, Novato, CA), had resistances of 2-5 MV after filling with 140 mM KCl, 2 mM MgCl 2 , 10 mM HEPES, and 5 mM EGTA, with the pH adjusted to 7.4 with KOH as previously described Nau, 2003, 2005; Spahn et al., 2013) . The ECS consisted of 140 mM NaCl, 5 mM KCl, 2 mM MgCl 2 , 10 mM glucose, 2 mM CaCl 2 , and 10 mM HEPES at pH 7.4 adjusted by NaOH. In experiments using DRG neurons, 10 mM forskolin and 2 mM isobutymethylxanthin were added to the solution. Recordings were performed at room temperature. Only small-sized sensory neurons (cell diameter #26 mm) sensitive to capsaicin (1 mM or 100 nM) and MO (20 mM) were included in the study. These cells were considered responsive if the inward current was at least 100 pA. Solutions were applied with a polytetrafluoroethylene glass multiple-barrel perfusion system. The PULSE software (HEKA Elektronik) was used for data acquisition and offline analysis.
Ratiometric [Ca 21 ] i Measurements. Transiently transfected cells were loaded with 3 mM of the fluorescent calcium indicator dye Fura-2-AM supplied with 0.02% pluronic F-127 (Invitrogen, Carlsbad, CA) for 20 minutes. Afterward, cells were washed with calcium imaging buffer (CIB) (140 mM NaCl, 2 mM CaCl 2 , 5 mM KCl, 10 mM glucose, 20 mM HEPES; adjusted to pH 7.4) to remove extracellular Fura-2-AM. MO (20 mM) was added to the culture plates with cover slips. After 2 minutes the cover slips were transferred to the measurement chamber and cells were covered with CIB (washout). One minute later the recording started and capsaicin was added. Every 2 seconds images were acquired using a charge-coupled device camera with a monochromator (Till Photonics, Gräfeling, Germany) coupled to an Eclipse TE 2000-second microscope (Nikon, Düsseldorf, For the CA-pretreated cells, the CA-induced TRPA1 current is also shown followed by washout and capsaicin-induced TRPV1 current. Numbers (n) of cells are given in brackets.
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Germany). Fura-2-AM was excited at 340 and 380 nm with 100-millisecond exposure time at 2 Hz. Fluorescence at more than 420 nm was collected. Background for both wavelength intensities was continuously recorded and subtracted. Results were reported as a ratio. Cells were continuously superfused with CIB. Experiments were performed at room temperature, and data were stored for offline analysis as described (Spahn et al., 2013) .
TRPV1 Expression. Binding of the labeled TRPV1 agonist [ 3 H]resiniferatoxin (RTX) was examined according to Szallasi et al. (1999) . Briefly, appropriate concentrations of membranes from cells transfected with TRPV1 and TRPA1, or with TRPV1 and the empty vector Ptre2 (100 mg) were prepared and incubated in assay buffer (50 mM Trizma, 0.25 mg/ml bovine serum albumin, pH 7.4) containing increasing concentrations of [ 3 H]RTX (100-2,400 pM) (39.2 Ci/mmol) (PerkinElmer, Waltham, MA) in the absence or presence of 10 mM unlabeled RTX to assess affinity by displacement.
cAMP Accumulation. The cAMP levels of transiently transfected HEK 293 Tet-On cells were measured using enzyme-linked immunosorbent assays (GE Healthcare, Buckinghamshire, UK) according to the manufacturer's instructions. Cells were pretreated for 20 minutes with the phosphodiesterase inhibitor isobuthylmethylxanthine (2 mM) and 10 mM forskolin to avoid cAMP degradation and induce AC activity, respectively (Xia et al., 2011) . TRPA1 was activated by 20 mM MO 5 minutes before the membrane preparation. Calcium was removed in the respective cells by the addition of 100 mM EGTA and 10 mM BAPTA-AM 12 hours prior to the experiment.
Statistics. Data are represented as means 6 S.E.M. Gaussian distribution was examined by the Shapiro-Wilk normality test. We used the unpaired t test and 1-way analysis of variance (ANOVA) with Dunnett's multiple comparison test for parametric data, and the Mann-Whitney test and Kruskal-Wallis with Dunn's multiple comparison test for nonparametric data. For grouped analyses we used 2-way ANOVA with Bonferroni multiple comparison test. Binding data are reported as means 6 S.E.M. of at least four independent experiments performed in duplicate. Differences were considered significant if P , 0.05. All tests were performed using Prism 5 (GraphPad Software, Inc., San Diego, CA) statistical software (Spahn et al., 2013) .
Results
Increased TRPV1 Activity after TRPA1 Stimulation. We first measured capsaicin (1 mM)-induced TRPV1 currents in transiently transfected HEK 293 Tet-On cells coexpressing wild-type TRPV1 and TRPA1. Pretreatment with 20 mM MO for 2 minutes followed by a 1-minute washout resulted in 3.3-fold increase of capsaicin-induced TRPV1 currents compared with control cells without MO pretreatment (Kruskal-Wallis test, P , 0.01). In the absence of TRPA1 or after inhibition by simultaneous application of the TRPA1-specific inhibitor HC-030031 (25 mM) this effect was not detected (Figs. 1A and 2, C and D).
Representative current traces of control and MO-pretreated cells are shown in Fig. 1B . Calcium imaging confirmed these data in that the capsaicin (100 nM)-induced change of the fura ratio over time, as well as the maximum change of the fura ratio of MO-pretreated cells was significantly higher compared with control cells ( Fig. 2A; 2-way ANOVA, P , 0.001; Fig. 2B ; Mann-Whitney test, P , 0.05). In cells only expressing TRPV1 ( Fig. 2E ; n 5 53) or TRPA1 ( Fig. 2F ; n 5 16), 20 mM MO or 1 mM capsaicin, respectively, had no effect.
To further exclude a direct effect of MO at TRPV1, we investigated another TRPA1 agonist, CA (100 mM). Pretreatment of TRPV1 and TRPA1 coexpressing HEK 293 cells with CA for 2 minutes followed by a 1-minute washout also resulted in a significantly increased capsaicin (100 nM)-induced TRPV1 current ( Fig. 1E ; Mann-Whitney test, P , 0.01). Representative current traces are shown in Fig. 1F .
To study sensory neurons natively expressing TRPV1 and TRPA1, we performed whole-cell patch-clamp experiments in small-to medium-sized DRG neurons. Again, MO pretreatment resulted in a significantly elevated capsaicin (100 nM)-induced TRPV1 current ( Fig. 1C ; Mann-Whitney test, P , 0.05). Representative current traces of control and MOpretreated cells are shown in Fig. 1D . Nearly 70% (69.2%) of capsaicin-responsive neurons also responded to MO, with an average MO (20 mM)-induced current of 20.44 6 0.1 nA, indicating TRPA1 expression. Only neurons responding to MO were analyzed.
To exclude the possibility that the increased capsaicininduced current is based on an additive TRPA1 current, TRPA1 was inhibited with HC-030031 (25 mM) immediately after MO (or vehicle) pretreatment. Capsaicin was applied in the presence of HC-030031. This treatment still resulted in significantly increased capsaicin-induced TRPV1 currents in HEK 293 Tet-On cells (Fig. 3, A and B ; Mann-Whitney test, P , 0.05). In DRG neurons this effect was similar but not statistically significant (not shown; Mann-Whitney test, P . 0.05). We further studied HEK 293 Tet-On cells coexpressing wt TRPV1 and D477A TRPA1. This mutant lacks calcium sensitivity (Zurborg et al., 2007) and therefore, increased intracellular calcium (e.g., due to TRPV1 activation) cannot activate TRPA1 and account for the increased current. These experiments also showed significantly increased capsaicininduced currents in the MO-pretreated group ( Fig. 3C ; MannWhitney test, P , 0.001).
Unaltered TRPV1 Expression in the Presence of TRPA1. Next, we examined whether TRPV1 and TRPA1 cotransfection may alter the TRPV1 expression level or (Fig. 4A) . The maximum number of [ 3 H]RTX binding sites on cells expressing only TRPV1 was 427.2 6 244.1 fmol/mg compared with 445.6 6 236.1 fmol/mg on TRPV1/TRPA1 coexpressing cells. The dissociation constants were 6.9 6 4.8 nM and 4.7 6 3.4 nM, (Fig. 4B) .
Increased TRPV1 Activity after TRPA1 Stimulation Is Dependent on Calcium, AC, and PKA. In transfected HEK cells the removal of extracellular calcium per se induced significantly increased TRPV1 currents under control conditions (with calcium: I 5 20.73 6 0.1 nA; without calcium: I 5 22.72 6 0.35 nA, unpaired t test, P , 0.001) and reversed the TRPV1 sensitization after TRPA1 stimulation with MO ( Fig. 5A ; unpaired t test, P . 0.05).
The unspecific AC inhibitor SQ 22.536 (100 mM) abolished the increased capsaicin-induced TRPV1 current after TRPA1 stimulation ( Fig. 5B ; control: I 5 21.42 6 0.31 nA; MO: I 5 22.0 6 0.54 nA; unpaired t test, P . 0.05). Enzyme-linked immunosorbent assays showed significantly elevated cAMP levels in TRPV1/TRPA1-expressing cells pretreated with MO compared with controls (1-way ANOVA, Bonferroni post hoc test, P , 0.05). This was not detectable in the absence of calcium or in the absence of TRPA1 (Fig. 5C) . In patch-clamp experiments the PKA inhibitor H89 (10 mM) prevented TRPV1 sensitization after TRPA1 stimulation ( Fig. 5D ; control:
I 5 21.34 6 0.2 nA; MO: I 5 22.06 6 0.55 nA; MannWhitney test, P . 0.05).
In DRG neurons the removal of extracellular calcium as well as the inhibition of PKA prevented TRPV1 sensitization after TRPA1 stimulation (i.e., capsaicin currents did not differ significantly between control and MO-pretreated cells) (Fig. 5 , E and F; calcium-free controls: I 5 21.12 6 0.27 nA; MO: I 5 20.58 6 0.07 nA, unpaired t test, P . 0.05; H89 controls: I 5 20.39 6 0.15 nA; MO: I 5 20.25 6 0.1 nA; Mann-Whitney test, P . 0.05).
Increased TRPV1 Activity after TRPA1 Stimulation Is Absent in TRPV1 Mutant S116A. We investigated PKA phosphorylation sites of TRPV1 by replacing S116, T144, and S774 by alanine, respectively. In HEK 293 Tet-On cells coexpressing mutant TRPV1 and wt TRPA1 the increased capsaicin-induced TRPV1 current after TRPA1 stimulation was absent in mutants S116A and S774A (Fig. 6 , A and C; unpaired t test, P . 0.05) but was still present in cells coexpressing T144A and wt TRPA1 (Fig. 6B , unpaired t test, P , 0.001). In microfluorimetry experiments the increased capsaicin-induced calcium mobilization after MO pretreatment was reversed in mutant S116A (Mann-Whitney test, P . 0.05, Fig. 7A ) but was still present in mutant T144A (unpaired t test, P , 0.001, Fig. 7B ) and in mutant S774A (unpaired t test, P , 0.01, Fig. 7C ).
Discussion
In the present study we showed increased TRPV1 activity after prestimulation of TRPA1, both in HEK cells and DRG neurons. This was dependent on calcium, AC, and PKA. Mutation of the putative phosphorylation site serine 116 in TRPV1 also abolished increased TRPV1 activity after TRPA1 stimulation. Together, our findings suggest that TRPA1 activation causes an influx of calcium and increases calciumsensitive AC activity, cAMP accumulation, and subsequent PKA activation. This results in phosphorylation and sensitization of TRPV1.
Although some studies showed direct activation of TRPV1 by MO at high concentrations (Ohta et al., 2007; Everaerts et al., 2011; Gees et al., 2013) , our control experiments and other studies showed that MO at a concentration of 20 mM did not directly activate TRPV1 ( Fig. 2D ; Jordt et al., 2004; Everaerts et al., 2011) .
Approximately 30% to 50% of TRPV1-expressing small-to medium-sized peripheral sensory neurons coexpress TRPA1, and almost all TRPA1-positive neurons coexpress TRPV1 (Story et al., 2003; Kobayashi et al., 2005; Hjerling-Leffler et al., 2007; Linte et al., 2007) . Furthermore, currents induced by the TRPA1 agonists MO and WIN55,212 were almost exclusively detected in TRPV1-positive cells (Story et al., 2003; Jordt et al., 2004; Diogenes et al., 2007) , and both channels are activated by compounds that cause a pungent burning sensation. Thus, we hypothesized that TRPV1 sensitization can result from functional interactions of both channels.
While most TRP channel complexes are made up of monomers from members of the same subfamily, numerous studies identified physical interactions between members of different TRP channel subfamilies through formation of heteromultimeric complexes (Schilling and Goel, 2004; Dietrich et Park et al., 2008) . Although it was shown that TRPV1 and TRPA1 can form such complexes, resulting in different pharmacological properties of the individual channels (Salas et al., 2009; Staruschenko et al., 2010; Ruparel et al., 2011) , we did not find any alterations in the amount of TRPV1 protein expression or binding in the presence of TRPA1 with the methods used in the current study. Previously, a stabilizing effect of TRPV1 on the membrane expression of TRPA1 was suggested . Internalization of membrane-bound channels can be suppressed by interactions with other proteins including subunits of the channels (Bernstein and Jones, 2007) , and functional TRPV1 tetramers can be modulated by cAMP-dependent translocation of TRPV1 monomers from intracellular pools to the cell membrane (Vetter et al., 2008) . Again, since neither the affinity nor the number of TRPV1 binding sites changed during TRPA1 activation, our experiments indicate that TRPV1 was not internalized or recruited to the cell membrane from intracellular pools.
Functional interactions between TRPV1 and TRPA1 via signaling pathways were suggested before, however, with some inconsistent results. One group showed inhibition of TRPV1 activity by TRPA1 via calcineurin-mediated desensitization of TRPV1 in Chinese hamster ovary cells and trigeminal ganglion neurons (Jeske et al., 2006; Akopian et al., 2007) . In these studies TRPA1 activation resulted in a recruitment of the calcium-dependent calcineurin pathway, whereby calcineurin dephosphorylated threonine 144 and 370 and subsequently desensitized TRPV1. In line with our results, CAMKII and PKC activation can increase TRPV1 activity after TRPA1 stimulation in a calcium-dependent manner (Jung et al., 2004; Mandadi et al., 2004) . Phosphorylation and dephosphorylation events might be dependent on calcium, TRPA1 agonist concentration, or incubation time.
Additionally, activation of calcium-sensitive ACs with subsequent PKA activation can induce TRP channel phosphorylation (Distler et al., 2003; Ferguson and Storm, 2004; Wang et al., 2008) . A recent study measured enhanced capsaicin responses of DRG neurons preincubated with low concentrations of CA (225 mM) in calcium imaging experiments, which indicated enhanced TRPV1 activity after pretreatment with a TRPA1 agonist (Anand et al., 2008) . Another group showed 
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that the TRPV1 response to mild acidification was significantly enhanced in the presence of 100 mM MO (Gees et al., 2013) . These findings are in line with our results showing that pretreatment with MO increased TRPV1 activity.
The activation of TRPA1 leads to an increase of intracellular calcium, since TRPA1 is a nonselective cation channel. Previous studies showed that calcium directly activates TRPA1 through an intracellular EF-hand domain (Zurborg Fig. 6 . Cells coexpressing mutant TRPV1 and wild-type TRPA1 in patch-clamp experiments. Capsaicin-induced TRPV1 currents of mutants S116A (A) and S774A (C) did not differ between Ctrl and MO-pretreated cells (unpaired t test, P . 0.05) but were still increased in mutant T144A (B) after MO pretreatment (unpaired t test, ***P , 0.001). Numbers of cells are given in brackets. Fig. 7 . Cells coexpressing mutant TRPV1 and wild-type TRPA1 in calcium imaging experiments. (A) Maximum capsaicin-induced fura ratios were not different after MO pretreatment in TRPV1 mutant S116A (Ctrl: n = 28; MO: n = 24; Mann-Whitney test, P . 0.05) but were significantly increased in mutant T144A (B); Ctrl: n = 120; MO: n = 70; unpaired t test, ***P , 0.001) and S774A (C); Ctrl: n = 71; MO: n = 54; unpaired t test; *P , 0.01). et al., 2007) , possibly resulting in an (auto) amplification of TRPA1 activity. This might induce an additive TRPA1 current due to calcium entering TRPV1 after capsaicin application. We excluded this possibility using the TRPA1 inhibitor HC-030031 or the calcium-insensitive TRPA1 mutant D447A. Therefore, we conclude that the increased TRPV1 activity after TRPA1 stimulation is only carried by TRPV1. In the present study TRPA1 activation failed to sensitize TRPV1 in the absence of calcium, suggesting an important role for calcium in mediating TRPV1 sensitization. In sensory neurons an increase of intracellular calcium can lead to elevated cAMP, elevated translocation of the catalytic PKA subunit via AC1 and AC8, and subsequently to increased TRPV1 phosphorylation (Distler et al., 2003) . In line with these findings, we measured increased cAMP levels after MO prestimulation, which were abolished in the absence of calcium or of TRPA1. Importantly, in native DRG neurons we also found a significant increase of capsaicin-induced TRPV1 activity after TRPA1 activation. This supports our results in transfected cells, suggesting that this mechanism also plays an important role in cells endogenously expressing TRPV1 and TRPA1.
Finally, we used TRPV1 mutants S116A, T144A, and S774A to identify potential PKA phosphorylation sites at TRPV1. TRPV1 sensitization after TRPA1 stimulation was absent in mutant S116A but not in T144A or S774A. This supports our hypothesis that TRPA1 prestimulation increases PKA activity and subsequently increases TRPV1 sensitivity at S116. This is in accordance with previous studies that identified S116 as a candidate PKA phosphorylation site for PKA-dependent TRPV1 sensitization (Bhave et al., 2002; Mohapatra and Nau, 2005) .
In summary, our data show that TRPA1 activation sensitizes TRPV1 in a calcium-and cAMP/PKA-dependent manner. The activation of TRPA1 resulted in an enhanced cAMP-accumulation, likely by the stimulation of calciumdependent ACs. The increased cAMP may stimulate the release of the catalytic PKA subunit, which in turn phosphorylates TRPV1 at the putative phosphorylation site serine 116. Concurrently, we detected calcium-sensitive increased TRPV1 activity after TRPA1 activation in DRG neurons. Future studies might identify new analgesics based on the prevention of TRPV1 sensitization.
